The problem of drug resistance due to long-term use of antibiotics has been a concern for
years. As this problem grows worse, infections caused by multiple bacteria are expanding …

We are experiencing an antimicrobial resistance (AMR) crisis, brought on by the drying up of
the antibiotic discovery pipeline and the resulting unchecked spread of resistant pathogens …

Antimicrobial peptides constitute one of the most promising alternatives to antibiotics since
they could be used to treat bacterial infections, especially those caused by multidrug …

Microbial resistance to antibiotics is an ancient and dynamic issue that has brought a
situation reminiscent of the pre-antibiotic era to the limelight. Currently, antibiotic resistance …

Many nanotechnology-based antimicrobials and antimicrobial-delivery-systems have been
developed over the past decades with the aim to provide alternatives to antibiotic treatment …

This review covers some of the recent progress in the field of peptide antibiotics with a focus
on compounds with novel or established mode of action and with demonstrated efficacy in …

The discovery of novel antibacterial molecules plays a key role in solving the current
antibiotic crisis issue. Natural products have long been an important source of drug …

Escherichia coli ST131 is one of the high-risk multidrug-resistant clones with a global
distribution and the ability to persist and colonize in a variety of niches. Carbapenemase …

The group of bacterial non-ribosomally produced peptides (NRPs) has formed a rich source
for drug development. Brevicidine, a bacterial non-ribosomally produced cyclic lipo …

Acinetobacter baumannii is an opportunistic pathogen predominantly associated with
nosocomial infections. With emerging resistance against polymyxins, synergistic …